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Carotid sinus syndrome is the association of carotid sinus hypersensitivity with syncope, un-
explained falls and drop attacks in generally older people. We evaluated cardiac sympathet-
ic innervation in this disorder in individuals with carotid sinus syndrome, asymptomatic
carotid sinus hypersensitivity and controls without carotid sinus hypersensitivity.
Methods
Consecutive patients diagnosed with carotid sinus syndrome at a specialist falls and synco-
pe unit were recruited. Asymptomatic carotid sinus hypersensitivity and non-carotid sinus
hypersensitivity control participants recruited from a community-dwelling cohort. Cardiac
sympathetic innervation was determined using Iodine-123-metaiodobenzylguanidine (123-
I-MIBG) scanning. Heart to mediastinal uptake ratio (H:M) were determined for early and
late uptake on planar scintigraphy at 20 minutes and 3 hours following intravenous injection
of 123-I-MIBG.
Results
Forty-two subjects: carotid sinus syndrome (n = 21), asymptomatic carotid sinus hypersen-
sitivity (n = 12) and no carotid sinus hypersensitivity (n = 9) were included. Compared to the
non- carotid sinus hypersensitivity control group, the carotid sinus syndrome group had sig-
nificantly higher early H:M (estimated mean difference, B = 0.40; 95% confidence interval,
CI = 0.13 to 0.67, p = 0.005) and late H:M (B = 0.32; 95%CI = 0.03 to 0.62, p = 0.032). There
was, however, no significant difference in early H:M (p = 0.326) or late H:M (p = 0.351)
between the asymptomatic carotid sinus hypersensitivity group and non- carotid sinus
hypersensitivity controls.
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Conclusions
Cardiac sympathetic neuronal activity is increased relative to age-matched controls in indi-
viduals with carotid sinus syndrome but not those with asymptomatic carotid sinus hyper-
sensitivity. Blood pressure and heart rate measurements alone may therefore represent an
over simplification in the assessment for carotid sinus syndrome and the relative increase in
cardiac sympathetic innervation provides additional clues to understanding the mecha-
nisms behind the symptomatic presentation of carotid sinus hypersensitivity.
Introduction
Carotid sinus hypersensitivity (CSH) may be associated with syncope in older people, and has
also been implicated in the etiology of unexplained falls and drop attack [1,2]. Asymptomatic
CSH is also known to occur, and is more common than previously anticipated [3], raising the
possibility that the exaggerated hemodynamic responses to carotid sinus massage are merely
age-related changes rather than CSH being a genuine pathological disorder. Previous work
from our group has highlighted altered cerebral autoregulation in patients with carotid sinus
syndrome (CSS) compared to control subjects, though the ultimate substrate for this process
remains obscure [4]. One candidate may be differences in autonomic function between such
individuals. A recent report by our group shows that CSS is associated with enhanced resting
sympathetic tone and baroreflex sensitivity [5], with similar results reported from observations
of Meyer wave activity in the vasodepressor subtype of CSS [6]. In addition, neuropathological
studies in patients with CSS have shown a high burden of hyperphosphorylated Tau protein in
medullary autonomic nuclei associated with baroreflex activity [7].
We hypothesize that autonomic function is altered in patients with CSS, and that cardiac
sympathetic innervation is enhanced in such individuals. In the study reported here, cardiac
meta-iodo-benzylguanidine (MIBG) imaging was used to provide a quantitative measure of
cardiac sympathetic innervation. This method is particularly useful in older individuals, as un-
like other methods using challenge manoeuvres, it requires minimal patient cooperation. We
are aware of no such imaging study in CSS. We, therefore, conducted a case-control study of
cardiac MIBG imaging in both patients with CSS, asymptomatic CSH and asymptomatic con-
trol subjects without CSH.
Methods
Ethics statement
This study was granted ethical approval by the Newcastle and North Tyneside Local Research
and Ethics Committee 2. Written informed consent was obtained from all participants. The
study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.
Participants
Participants with CSS were recruited from consecutive patients diagnosed with CSH during
investigations for syncope, unexplained falls or drop attacks at a specialist syncope facility.
Control participants with and without CSH were recruited from an asymptomatic community
cohort evaluated with carotid sinus massage in an epidemiological study [3]. Potential partici-
pants were excluded if they were unable to provide informed consent, had a history of thyroid
disorders or diabetes mellitus; were taking tricyclic antidepressants or other
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sympathomimetics; and if there was established ischemic heart disease or clinical features sug-
gestive of heart disease.
Carotid sinus massage
Carotid sinus hypersensitivity was defined as at least three seconds of asystole or a reduction in
systolic blood pressure of at least 50mmHg in response to carotid sinus massage. Carotid sinus
syndrome was diagnosed if such a response coincided with symptoms reproducing the patient’s
original presentation in the absence of a competing cause for such symptoms following com-
prehensive evaluation in accordance with European Society of Cardiology guidelines [8]. Ca-
rotid sinus massage was conducted during continuous electrocardiography and beat-to-beat
blood pressure monitoring (Taskforce, CNSystems, Austria) in a bilateral sequential fashion.
The position of the carotid sinus was determined by the area of maximal pulsation of the carot-
id artery, two finger-breadths below of the angle of the mandible, lateral to the thyroid carti-
lage. Five seconds of longitudinal massage was first performed on the right followed by the left
with the patient in the supine position. If no positive response was achieved during supine ca-
rotid sinus massage, the procedure was repeated with the patient in an upright position, at a
70° tilt-angle on a tilt-table with a footplate [9].
Cardiac meta-iodo-benzylguanidine scan
The patients and asymptomatic community dwellers with and without CSH who consented
to the study were invited to attend the Medical Physics Department on a separate occasion.
Two doses of potassium iodate 170mg were administered in the preceding 24 hours for thyroid
blockade. Participants were injected with 150 MBq of 123-iodine radiolabelled MIBG (123-I-
MIBG) administered through a peripheral vein. Early (20 minutes) and delayed (3 hours) pla-
nar thoracic scintigraphic images were obtained in an anterior projection using a large field
gamma camera fitted with a low energy high-resolution collimator. Static images were collected
for 15 minutes with a 20% window centred on the 159keV, 123-I photopeak.
On the early anterior view, an oval shaped region of interest was drawn tightly and semi au-
tomatically around the entire heart avoiding as far as possible any confounding activity from
adjacent left lung (Fig 1). A small square reference region of interest was drawn in the upper
mediastinum between the lung apices [10]. Relative uptake by the heart was determined using
the heart to mediastinal (H:M) ratio using the average counts per pixel of the ventricular and
mediastinal ROI’s for both early and delayed images. The percentage washout rate (%WR) was
calculated using the formula: %WR = [(H:M)early–(H:M)late]/ (H:M)early  100. In all cases,
late H and M uptake values were corrected for 3 hours of radioactive decay. Ten randomly se-
lected cases were reanalyzed by the same observer and an independent observer to test intraob-
server and interobserver agreement. Both observers followed a standardised method of analysis
and were blinded to the groups of the study.
Data analysis
Histogram plots and the Komolgorov-Smirnov test were used to confirm that continuous vari-
ables were normally distributed. Continuous variables were then expressed as mean with 95%
confidence intervals, while categorical data were presented as count with percentages in paren-
theses. Participant characteristics were compared with analysis of variance for continuous
variables and the Chi-squared test for categorical variables. Interobserver and intraobserver re-
liability were determined with Pearson’s correlation. Comparisons for early H:M ratio, late H:
M ratio and washout rate were made between the CSS group versus non-CSH controls and the
asymptomatic CSH group versus non-CSH controls using linear regression methods, based on
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our hypothesis generated a priori that CSH is associated with changes in cardiac sympathetic
innervation. Stepwise entry was used for the potential confounders of age, sex, co-existing med-
ical conditions and medications. The B coefficient therefore represents the estimated mean dif-
ferences between groups. A two-tailed p-value of< 0.05 was considered statistically significant.
All statistical analyses were performed using the SPSS™ 15.0 software package.
Fig 1. Early and delayedmyocardial planar scintigraphy of (A) a participant with symptomatic CSS and (B) an asymptomatic control participant
without CSH. The circles (2) highlight the regions of interest for the heart and the squares (1) highlight the mediastinal reference region.
doi:10.1371/journal.pone.0126241.g001
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Results
Participant characteristics
Forty-two participants mean age 74 years (range 52 to 90 years) were recruited, 21with CSS, 12
with asymptomatic CSH and 9 asymptomatic controls from the same community cohort who
did not have CSH. The characteristics of participants in the above three groups are listed in
Table 1.There was a significant difference in the use of lipid-lowering drugs between the
three groups (p<0.05), but no other significant differences were present for the remaining
characteristics.
Univariate analyses
The intraobserver and interobserver values for the H:M uptake ratios showed good correlation
at r = 0.997 and r = 0.994 respectively. Fig 1 shows the 123-I-MIBG scintigraphs for two partic-
ipants, an asymptomatic control subject without CSH, and the other with CSS with much
Table 1. Characteristics of Study Participants.
Characteristics CSS (n = 21) Asymptomatic CSH (n = 12) Non-CSH controls (n = 9) p-valuea
Age (Years), mean ± SD 72 ± 10 77 ± 4 74 ± 3 0.248b
Male Gender, n(%) 9 (43) 10 (83) 5 (56) 0.077
CSH classification, n(%)
Cardioinhibitory 11 (52) 6 (50)
Vasodepressor 10 (48) 6 (50)
Resting HR (bpm), mean ± SD 73.4 ± 11.5 65.9 ± 13.9 60.0 ± 4.8 0.027
Min HR (bpm), mean ± SD 27.6 ± 19.7 26.4 ± 17.9 48.4 ± 12.7 0.031
Max SBP drop (mmHg), mean ± SD 60.5 ± 11.9 60.3 ± 14.5 33.4 ± 11.4 <0.001
Medical History, n(%)
Atrial Fibrillation 1 (5) 1 (8) 1 (11) 0.811
Osteoarthritis 5 (24) 6 (50) 4 (44) 0.264
Asthma/COPD 4 (19) 2 (17) 2 (22) 0.950
Cerebrovascular disease 2 (10) 1 (8) 1 (11) 0.977
Hypertension 9 (43) 5 (42) 4 (44) 0.992
Osteoporosis 2 (10) 0 3 (33) 0.059
Medications, n(%)
Antiplatelets/ anticoagulants 8 (38) 3 (25) 0 0.093
Antipsychotics 2 (10) 2 (17) 0 0.437
Antidepressants 2 (10) 0 1 (11) 0.518
α-adrenoceptor antagonists 1 (5) 0 1 (11) 0.497
β-blockers 1 (5) 0 2 (22) 0.123
ACE- inhibitor 6 (29) 0 1 (11) 0.093
Calcium-channel antagonists, 4 (19) 2 (17) 2 (22) 0.950
Diuretics 4 (19) 1 (8) 3 (33) 0.353
Lipid-lowering agents 9 (43) 2 (17) 0 0.034
Steroids 3 (14) 0 1 (11) 0.398
Proton-pump inhibitors 5 (24) 2 (17) 0 0.276
CSS:carotid sinus syndrome; CSH:carotid sinus hypersensitivity; SD:standard deviation; HR:heart rate; SBP: systolic blood pressure; COPD:chronic
obstructive pulmonary disease; ACE:angiotensin-converting enzyme.
a χ2-test unless indicated otherwise.
b Analysis of variance.
doi:10.1371/journal.pone.0126241.t001
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higher cardiac MIBG uptake. The early H:M uptake ratios for individuals in the three groups
are illustrated in Fig 2, while Fig 3 shows the late H:M uptake ratios for individuals in the three
groups. The mean early H:M uptake ratios for the CSS, asymptomatic CSH and non-CSH con-
trol groups were 1.91 (95%CI = 1.76 to 2.06), 1.69 (95%CI = 1.44 to 1.94), and 1.51 (95%
CI = 1.33 to 1.69) respectively. The mean late H:M ratios for the CSS, asymptomatic CSH and
non-CSH control groups were 1.80 (95%CI = 1.62 to 1.98), 1.63 (95%CI = 1.38 to1.87) and
1.47 (95%CI = 1.30 to 1.64) respectively. The mean %WR was 19.2 (95%CI = 15.7 to 22.6)% for
the symptomatic CSS group, 16.8(95%CI = 12.8 to 20.9)% for the asymptomatic CSH group
and 14.5 (95%CI = 10.5 to 18.5)% for the non-CSH control group.
Multivariate analyses
Linear regression analyses with stepwise entry for potential confounders revealed that the early
H:M uptake ratio in individuals with CSS was significantly higher than non-CSH controls
Fig 2. Early Heart to Mediastinal Uptake Ratios. Filled circles, empty circles, and triangles represent
individual values, while horizontal lines represent mean values. H:M, heart to mediastinal uptake ratio; CSS,
carotid sinus syndrome; aCSH, asymptomatic carotid sinus hypersensitivity; no CSH, no carotid
sinus hypersensitivity.
doi:10.1371/journal.pone.0126241.g002
Fig 3. Late Heart to Mediastinal Uptake Ratios. Filled circles, empty circles, and triangles represent
individual values, while horizontal lines represent mean values.H:M, heart to mediastinal uptake ratio;CSS,
carotid sinus syndrome; aCSH, asymptomatic carotid sinus hypersensitivity; no CSH, no carotid sinus
hypersensitivity.Symbols represent individual values, while horizontal lines represent mean values.
doi:10.1371/journal.pone.0126241.g003
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(p = 0.005) (Table 2). The late H:M ratio was also significantly higher in the CSS group com-
pared to the non-CSH control group (p = 0.032). There was, however, no significant difference
in early or late H:M ratio between the asymptomatic CSH group compared to the non-CSH
control group. There were also no significant differences in decay adjusted %WR between the
CSS group and the non-CSH control group, or the asymptomatic CSH group and the non-




Our study was the first to examine cardiac sympathetic innervation through 123-I-MIBG myo-
cardial scintigraphy in both CSS and asymptomatic CSH, and controls without CSH. The CSS
group had higher early and late H:M uptake ratios than the non-CSH control group. There
were no differences in either ratio between the asymptomatic CSH group and the non-CSH
control group. These findings indicate that sympathetic presynaptic neuronal uptake is en-
hanced in individuals with CSS but not those with asymptomatic CSH. There was, however, no
notable difference in %WR which has been considered a marker of sympathetic activity.
Relationship with existing literature
123-I-MIBG scanning has previously shown higher H:M ratios in head-up tilt positive paediat-
ric patients with vasovagal syncope [11], though an uncontrolled study in adult vasovagal pa-
tients showed more variable regional uptake deficits [12]. A more recent study in 60 patients
with vasovagal syncope and 20 controls found lower H:M ratios in the vasovagal patients
though with highly variable adrenergic innervation deficits in the left ventricular myocardium
[13]. These variable and contradictory results in vasovagal syncope suggest the need for consid-
erably more work in this area before definitive conclusions can be drawn. In contrast, sympa-
thetic neuroimaging using 123-I-MIBG scanning has been used extensively in cardiac risk
evaluation, in particular in the prognosis of cardiac failure and related risks of ventricular
tachyarrhythmias in such patients [14]. It also has a role in the investigation of the alpha-synu-
cleinopathies, providing a reliable method of identifying patients with Parkinson’s disease ver-
sus control subjects and those with multiple systems atrophy [15,16]. Intriguingly, a recent
study in 24 patients with Parkinson’s disease, 10 of whom had syncope or pre-syncope com-
pared to 14 controls, found that late phase uptake of MIBG was associated with day-time mini-
mum systolic blood pressure [17], raising the possibility of the identification of patients with
Parkinson’s who may be more likely to develop syncope. We have previously shown post-mor-
tem autonomic brain stem nuclei associated alpha-synucleinopathy in a patient with carotid
Table 2. Multivariate Regression Analysis Displaying Mean Differences in Early and Late H:M Between Groups Compared to Control Participants.
CSS (n = 21) vs. non-CSH controls (n = 9) Asymptomatic CSH (n = 12) vs.non-CSH
controls (n = 9)
Adjusted MD (95% CI) p-value Adjusted MD (95% CI) p-value
Early H:M 0.40 (0.13, 0.67) 0.005 0.18 (-0.12, 0.47) 0.236
Late H:M 0.32 (0.03, 0.62) 0.032 0.15 (-0.17, 0.48) 0.351
% Washout 4.70 (-0.69, 10.1) 0.086 2.34 (-3.63, 8.31) 0.433
CSS: carotid sinus syndrome; CSH: carotid sinus hypersensitivity; MD: mean difference; CI: confidence interval; H:M: heart to mediastinal MIBG uptake;
%WR: percentage washout rate adjusted for decay.
doi:10.1371/journal.pone.0126241.t002
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sinus syndrome with no clinical evidence of movement disorder, raising the possibility of a
causative mechanism for our current findings and for CSS in general [18].
Control subjects in previous studies had included patients with negative CSM or asymptom-
atic controls with unknown CSH status. CSH has been associated with sternocleidomastoid de-
nervation [19], increased baroreflex sensitivity [20,21] and paradoxical peripheral
vasodilatation [22]. We have recently shown alterations in baroreflex sensitivity and heart rate
variability in patients with CSS [5], while others have shown altered Mayer wave activity in pa-
tients with CSH [6]. Given these findings, and the observation of brain stem degenerative
changes in patients with CSS versus age-matched controls [7], we hypothesised that CSS was
part of a more widespread autonomic nervous system disorder. In particular, cardiac sympa-
thetic innervation would differ in patients with CSS versus those with CSH and no symptoms,
and controls with demonstrably no CSH and no symptoms. This last is a particular strength of
our study–the CSH status of all participants was known in contrast to many of the studies
mentioned above.
Explanation of findings
We have shown that cardiac MIBG uptake is increased in individuals with CSS compared to
matched controls without CSH. Meta-iodo-benzylguanidine is an analogue of norepinephrine
which is not metabolized in humans, and therefore excreted unchanged. The heart is normally
enriched with sympathetic nerve endings which also have a high affinity for MIBG, and this
property can be used to perform quantitative assessments of the integrity of cardiac sympathet-
ic nerves [23,24]. These findings are complementary to that demonstrated in the recently pub-
lished evidence that resting sympathetic activity is increased in individuals with CSH [5].
Meta-iodo-benzylguanidine is preferentially taken up by the active transporter system (uptake-
1) at sympathetic nerve terminals [25]. An increase in MIBG uptake may therefore be due to ei-
ther increased neuronal activity leading to increased active transporter uptake or a higher den-
sity of sympathetic neurons. Cardiac MIBG uptake is also known to decrease with age [26].
The enhanced MIBG uptake observed in our CSS participants may also signify a relative pres-
ervation of sympathetic cardiac innervation against the effects of aging. This may have oc-
curred as a result of chronic sympathetic activation, which is a feature of aging [27], in the
presence of loss of negative feedback. The chronic, unregulated, increase in sympathetic out-
flow may then result in desensitization of post-synaptic adrenergic receptors manifesting as at-
tenuated sympathetic responses during carotid sinus massage.
The relative increase in MIBG uptake observed in the CSS group over the non-CSH control
group was, however, not observed in individuals with asymptomatic CSH. The difference in
presynaptic neuronal uptake may not, therefore, necessarily account for the heart rate and
blood pressure changes that are recorded, but instead appears to be associated with the clinical
symptoms that occur with the measured hemodynamic changes. This raises the possibility, re-
inforcing previous clinical suspicions, that the current practice of assessing heart rate and sys-
tolic blood pressure changes alone represents an over simplistic method of assessing overall
physiological responses during clinical investigations to evaluate syncope. In addition, this also
indicates that individuals with CSH who develop symptoms of falls or syncope have different
autonomic responses to asymptomatic individuals, which suggests that CSS is indeed a patho-
logical condition rather than just a feature of normal aging.
The interpretation of the lack of difference in %WR is unclear in the presence of increased
early and late H:M uptake. While the washout rate is considered an index of sympathetic drive
[28], washout may, however, also signify increased diffusional uptake and increased clearance
from the extravesicular pool in individuals with defective active transporter uptake [29,30].
Cardiac Sympathetic Innervation in Carotid Sinus Hypersensitivity
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This together with the lack of standardisation of both the acquisition and the analysis of all
123-I- MIBG studies involving cardiac uptake [27] may also have contributed to the failure to
identify a lack of anticipated %WR difference between groups in this study.
Limitations
While the number of participants involved in our study outnumbers all the previous studies
evaluating the pathophysiological changes associated with CSH published so far, the actual
number remains relatively small, introducing the possibility of false negative results. The clini-
cal applicability of our study is also limited by the potential for overlap between the three
groups. Nevertheless, the presence of increased or even preserved cardiac sympathetic innerva-
tion in CSS represents an entirely new finding, which at the very least deserves further evalua-
tion. This may well represent the early steps towards the identification of an additional
therapeutic target for this increasingly important condition. While treatment in CSS reduces
syncope recurrence to 7% at 1 year, at 5 years 26% have recurrence of symptoms regardless of
treatment modality [31], so this is far from an academic issue [5].
Conclusion
Cardiac MIBG uptake was significantly increased in symptomatic individuals with CSH com-
pared to controls without CSH, with no corresponding increase in asymptomatic individuals
with CSH and no apparent changes in %WR. The absence of changes in MIBG uptake in
asymptomatic individuals with CSH highlights possible inadequacies of heart rate and blood
pressure measurements in assessing the overall response to carotid sinus massage. The symp-
tomatic presentation of CSH, carotid sinus syndrome, however, appears to be associated with
heightened cardiac sympathetic neuronal activity. This represents an important development
in the search for potential therapeutic targets for CSS which is now urgently required.
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